The Role of Pre-emptive Analgesia With Qutenza (Topical Capsaicin 8%) in Preventing Neuropathic Pain Following Lower Limb Amputation: a Pilot Randomised Controlled Study

Trial Profile

The Role of Pre-emptive Analgesia With Qutenza (Topical Capsaicin 8%) in Preventing Neuropathic Pain Following Lower Limb Amputation: a Pilot Randomised Controlled Study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Capsaicin (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma Europe Ltd
  • Most Recent Events

    • 21 Dec 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2012-001587-30).
    • 26 Sep 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
    • 14 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top